Literature DB >> 9342359

Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin.

O Devergne1, M Birkenbach, E Kieff.   

Abstract

The Epstein-Barr virus-induced gene 3 (EBI3) is a novel soluble hematopoietin component related to the p40 subunit of interleukin 12 (IL-12). When EBI3 was expressed in cells, it accumulated in the endoplasmic reticulum and associated with the molecular chaperone calnexin, indicating that subsequent processing and secretion might be dependent on association with a second subunit. Coimmunoprecipitations from lysates and culture media of cells transfected with expression vectors for EBI3 and/or the p35 subunit of IL-12 now reveal a specific association of EBI3 with p35. Coexpression of EBI3 and p35 mutually facilitates their secretion. Most importantly, a large fraction of p35 in extracts of the trophoblast component of a human full-term normal placenta specifically coimmunoprecipitated with EBI3, indicating that EBI3 is in a heterodimer with p35, in vivo. Because EBI3 is expressed in EBV-transformed B lymphocytes, tonsil, spleen, and placental trophoblasts, the EBI3/p35 heterodimer is likely to be an important immunomodulator.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342359      PMCID: PMC23696          DOI: 10.1073/pnas.94.22.12041

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Molecular characterization of interleukin 12.

Authors:  F J Podlaski; V B Nanduri; J D Hulmes; Y C Pan; W Levin; W Danho; R Chizzonite; M K Gately; A S Stern
Journal:  Arch Biochem Biophys       Date:  1992-04       Impact factor: 4.013

Review 2.  Structural and functional diversity of the platelet-derived growth factor.

Authors:  T F Deuel
Journal:  Curr Opin Biotechnol       Date:  1991-12       Impact factor: 9.740

3.  Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.

Authors:  S F Wolf; P A Temple; M Kobayashi; D Young; M Dicig; L Lowe; R Dzialo; L Fitz; C Ferenz; R M Hewick
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

4.  Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.

Authors:  J Menezes; W Leibold; G Klein; G Clements
Journal:  Biomedicine       Date:  1975-07

5.  IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts.

Authors:  R Chizzonite; T Truitt; F J Podlaski; A G Wolitzky; P M Quinn; P Nunes; A S Stern; M K Gately
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

6.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

8.  Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.

Authors:  A S Stern; F J Podlaski; J D Hulmes; Y C Pan; P M Quinn; A G Wolitzky; P C Familletti; D L Stremlo; T Truitt; R Chizzonite
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

9.  Cloning and expression of murine IL-12.

Authors:  D S Schoenhaut; A O Chua; A G Wolitzky; P M Quinn; C M Dwyer; W McComas; P C Familletti; M K Gately; U Gubler
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

10.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

Authors:  A D'Andrea; M Rengaraju; N M Valiante; J Chehimi; M Kubin; M Aste; S H Chan; M Kobayashi; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  107 in total

1.  Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

Authors:  Hajir Dadgostar; Brian Zarnegar; Alexander Hoffmann; Xiao-Feng Qin; Uyen Truong; Govinda Rao; David Baltimore; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 2.  A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.

Authors:  Brian Astry; Erin Harberts; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

3.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

4.  Adenovirus-mediated interleukin-35 gene transfer suppresses allergic airway inflammation in a murine model of asthma.

Authors:  Yan Li; Xiuhe Pan; Xiao Peng; Shubo Li; Yanchun Zhou; Xiaoxuan Zheng; Mingcai Li
Journal:  Inflamm Res       Date:  2015-08-30       Impact factor: 4.575

Review 5.  Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.

Authors:  Charles E Egwuagu; Cheng-Rong Yu; Lin Sun; Renxi Wang
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-20       Impact factor: 7.638

6.  Assessing the role of IL-35 in colorectal cancer progression and prognosis.

Authors:  Jin-Cheng Zeng; Zhi Zhang; Tian-Yu Li; Yan-Fang Liang; Hong-Mei Wang; Jing-Jing Bao; Jun-Ai Zhang; Wan-Dang Wang; Wen-Yu Xiang; Bin Kong; Zhi-Yong Wang; Bin-Hua Wu; Xiao-Dong Chen; Long He; Shu Zhang; Cong-Yi Wang; Jun-Fa Xu
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

7.  Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma.

Authors:  Xiangting Qiu; Xinhua Wang; Yucui Song; Lingling Chen
Journal:  Dig Dis Sci       Date:  2016-10-03       Impact factor: 3.199

8.  Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer.

Authors:  Xiaobin Gu; Tian Tian; Bo Zhang; Yang Liu; Chao Yuan; Lijuan Shao; Yajun Guo; Kexing Fan
Journal:  Tumour Biol       Date:  2014-12-06

9.  Interleukin (IL)-35 Suppresses IL-6 and IL-8 Production in IL-17A-Stimulated Human Periodontal Ligament Cells.

Authors:  Satoru Shindo; Yoshitaka Hosokawa; Ikuko Hosokawa; Hideki Shiba
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 10.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.